4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-21-036600
Chief Commercial Officer sold 6,238 shares at $6.73 ($41,982)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Deardorf Caren Chief Commercial Officer | 2021-09-16 | Sale | −6,238 | $6.73 | $41,982 | 13,762 | D |
| Open-market sales · 6,238 sh · avg $6.73 · $41,982 | |||||||
Loading xslF345X03/doc4.xml…